                                                                                                                                      MBoCâ€‚ |â€‚ ARTICLE



 E3 ubiquitin ligase mind bomb 1
ubiquitinates promotes degradation survival motor neuron protein
Deborah Y. Kwona,b, Maria Dimitriadib, Barbara Terzica, Casey Cablea, Anne C. Hartb, Ajay Chitnisc,
Kenneth H. Fischbecka, Barrington G. Burnetta  Neurogenetics Branch, National Institute Neurological Disorders Stroke, National Institutes Health,
Bethesda, MD 20892; bDepartment Neuroscience, Brown University, Providence, RI 02912; cProgram Genomics Development, Eunice Kennedy Shriver National Institute Child Health Human Development, National
Institutes Health, Bethesda, MD 20892




ABSTRACTâ€‚ Spinal muscular atrophy inherited motor neuron disease results                                  Monitoring Editor
deficiency survival motor neuron (SMN) protein. SMN ubiquitinated degraded                                 William P. Tansey
                                                                                                                            Vanderbilt University ubiquitin proteasome (UPS). previously shown proteasome
inhibition increases SMN protein levels, improves motor function, reduces spinal cord,                                  Received: Jan 18, 2013
muscle, neuromuscular junction pathology spinal muscular atrophy (SMA) mice. Spe-                                    Revised: Apr 8, 2013
cific targets UPS efficacious toxic. study,                            Accepted: Apr 16, 2013
E3 ubiquitin ligase, mind bomb 1 (Mib1), interacts ubiquitinates SMN facilitates degradation. Knocking Mib1 levels increases SMN protein levels cultured cells.  knocking Mib1 orthologue improves neuromuscular function Caenorhabditis
elegans deficient SMN. findings demonstrate Mib1 ubiquitinates catalyzes degradation SMN, represents novel therapeutic target SMA.



INTRODUCTION
Spinal muscular atrophy (SMA) autosomal recessive neurologi-                     rapidly degraded (Coovert etÂ  al., 1997; Lorson etÂ  al., 1999;
cal disorder characterized loss lower motor neurons, leading                     Lorson Androphy, 2000; Monani etÂ  al., 1999; Burnett etÂ  al., weakness skeletal muscle atrophy, leading                  2009). Human SMN2 transgenic mice mitigates severity genetic causes infant death. 90  SMA results                      SMA disease phenotype mouse smn-null background, deletion survival motor neuron (SMN1) gene, patients                   gene dosage effect (Hsieh-Li etÂ al., 2000). Patients mild SMA
retaining copy homologue SMN2 (Lefebvre etÂ al.,                    phenotypes SMN2 copies, indi-
1995). SMN1 produces predominantly length SMN pro-                          viduals SMN2 genes pheno-
tein, SMN2 contains translationally silent C T transition                  typically normal (Lefebvre etÂ al., 1995; McAndrew etÂ al., 1997; Prior
exon 7, causing exon skipped mRNA                             etÂ al., 2004).
splicing producing truncated protein (SMNÎ”7) unstable                        SMN degraded ubiquitin proteasome                                                                                        (UPS; Chang etÂ al., 2004; Burnett etÂ al., 2009; Kwon etÂ al., 2011).
                                                                                        proteins destined degradation tagged link-
                                                                                       age ubiquitin action enzymes: E1 (ubiquitin- article published online ahead print MBoC Press (http://www
.molbiolcell.org/cgi/doi/10.1091/mbc.E13-01-0042) April 24, 2013.                   activating), E2 (ubiquitin-conjugating), E3 (ubiquitin ligase) authors declare conflict                             (Petroski, 2008). E3 ligases confer substrate specificity Address correspondence  Barrington G. Burnett (burnettb@ninds.nih.gov).             process considered candidates targeted
Abbreviations used: Mib1, mind bomb 1; NMJ, neuromuscular junction; RING,              inhibition protein degradation.
really interesting new gene; SMA, spinal muscular atrophy; SMN, survival motor
neuron; UPS, ubiquitin proteasome                                                   shown SMN protein levels increased cell
Â© 2013 Kwon etÂ al. article distributed American Society Cell Bi-    culture animal models inhibition proteasome (Burnett
ology license author(s). months publication available   etÂ al., 2009; Kwon etÂ al., 2011). protein degradation public Attributionâ€“Noncommercialâ€“Share Alike 3.0 Unported
Creative Commons License (http://creativecommons.org/licenses nc-sa/3.0).
                                                                                       UPS essential process cellular homeostasis general inhi-
â€œASCBÂ®,â€?  American Society Cell BiologyÂ®,â€? â€œMolecular Biology           bition undesired effects, sought identify char- CellÂ®â€? registered trademarks American Society Cell Biology.          acterize E3 ligase(s) responsible specifically targeting SMN


Volume 24â€ƒ June 15, 2013	                                                                                                                             1863â€ƒ
 degradation. chose evaluate mind bomb 1 (Mib1)              uitinated proteins, consistent results cultured cells (Figure
candidate, based role inhibiting outgrowth neurites       1C). Given Mib1 ubiquitinates SMN, sought quantify cultured neurons (Choe etÂ al., 2007). Loss Drosophila melano-        effect Mib1 SMN protein turnover. performed pulseâ€“
gaster Mib1 increases number synaptic boutons neuromus-          chase analysis using HEK-293T cells transfected wild-type
cular junctions (NMJs), producing synaptic overgrowth, reduc-        Mib1-myc active-site mutant, Mib1-C1009S-myc, deter-
tion SMN reduces number NMJ boutons D. melanogaster           E3 ligase activity Mib1 alters SMN protein half- results aberrantly truncated motor neurons Danio rerio           life. overexpressing wild-type Mib1 decreased (McWhorter etÂ  al., 2003; Choe etÂ  al., 2007; Chang etÂ  al., 2008).        half-life newly synthesized radiolabeled SMN half, âˆ¼4 Mib1 multidomain enzyme carboxyl-terminal really           2 h, compared active-site Mib1 mutant (Figure 1D). addi-
interesting new gene (RING) finger domains (Jin etÂ al., 2002; Itoh         tion, overexpressing Mib1 NSC34 cells reduced steady-state
etÂ al., 2003; Yoo etÂ al., 2006; Zhang etÂ al., 2007). best-character-   levels SMN protein, effect blocked protea-
ized role activating Delta-Notch signaling pathway,        inhibitor bortezomib (Figure 2A), indicating Mib1 targets
controls differentiation regulating cellâ€“cell communication (Itoh       SMN proteasomal degradation.
etÂ al., 2003; Chen Casey Corliss, 2004; Barsi etÂ al., 2005; Koo            SMN complex assembled cytoplasm etÂ  al., 2005a; Lai etÂ  al., 2005). functions Mib1      imported nucleus, localizes Cajal bodies emerged. Mib1 identified postsynaptic densities,            gems. number SMN-positive nuclear bodies shown function binding partner            used measure evaluating changes functional SMN protein
CDK5 complex regulating morphogenesis postmitotic neurons            levels (Coovert etÂ al., 1997; Jarecki etÂ al., 2005; Wolstencroft etÂ al.,
(Choe etÂ  al., 2007) regulating apoptosis promoting          2005). counted number SMN-positive nuclear puncta proteasomal degradation anti-apoptotic factor death-associ-         nucleus assessed fluorescence intensity HeLa cells 
ated protein kinase (DAPK; Jin etÂ al., 2002). Recently overexpres-         expressing wild-type Mib1 mutant Mib1-C1009S. sion Mib1 shown promote ubiquitination receptor-          number intensity SMN-positive bodies significantly
like tyrosine kinase (RYK), reducing steady-state levels        reduced cells overexpressing wild-type Mib1 compared 
plasma membrane (Berndt etÂ al., 2011).                                     transfected cells (Alexa Fluor 488â€“negative) express-
    study, SMN interacts Mib1           ing Mib1-C1009S (p < 0.0001, Figure 2B).  data
overexpression Mib1 cultured cells increases SMN ubiquitina-         demonstrate Mib1 determines SMN protein levels promot-
tion degradation. Importantly, Mib1 knockdown results            ing ubiquitination subsequent degradation.
creased SMN levels cultured cells ameliorates neuromus-
cular pharyngeal pumping defect Caenorhabditis elegans                  Reducing Mib1 expression increases SMN protein levels
deficient SMN, indicating physiological role Mib1 modu-        Mib1 overexpression decreased SMN levels inves-
lating SMN.                                                                tigated decreasing Mib1 increases SMN levels. trans-
                                                                           fected HEK-293T cells Mib1 small interfering RNA (siRNA) RESULTS                                                                    scrambled control, confirmed RT-PCR Mib1 levels
Mib1 increases SMN ubiquitination protein turnover                     reduced half 72 h transfection Mib1
E3 ligases promote protein degradation catalyzing transfer       siRNA (Figure 3A). Importantly, SMN protein levels significantly
ubiquitin molecules E2 enzyme substrate proteins.         increased Mib1 knocked (p < 0.001, Figure 3A). determine Mib1 ubiquitinates SMN, cotransfected             previously reported microRNA miR-137 targets
motor neuronâ€“derived hybrid cell line, NSC34, hemagglutinin           Mib1 mRNA regulates protein expression (Smrt etÂ al., 2010).
(HA)-tagged ubiquitin length selected domains myc-          sought determine overexpressing miR-137 af-
tagged Mib1. cells lysed buffer containing ubiq-          fects SMN protein levels. confirmed transfection cells
uitin aldehyde inhibit deubiquitination immunoprecipitated          miR-137 decreased Mib1 mRNA protein levels (Figure 3B), antibody SMN. ensure ubiquitin-positive             SMN levels increased cells transfected
bands Western blot ubiquitinated SMN ubiq-             miR-137 compared scrambled microRNA control (Figure
uitinated proteins associated SMN, disassociated SMN          3B). Importantly, confirmed short hairpin RNA (shRNA) binding partners immunoprecipitation denaturing              knockdown Mib1 increases SMN protein levels SMA patientâ€“ 1  SDS, followed renaturation 4.5  Triton X-100.           derived fibroblasts (Figure 3C). SMN transcript levels  conditions sufficient dissociate SMN known              changed siRNA Mib1 miR-137 (Figure 3D).  using
binding partners (Supplemental Figure S1). Immunoblots immu-            independent techniques cell lines shown
noprecipitated SMN probed anti-HA antibody detect             reducing Mib1 expression results increased SMN protein
ubiquitinated SMN. ubiquitination endogenous SMN,                levels.
indicated high-molecular-weight, ubiquitin-positive smear, increased cells expressing length, truncated active-    Interaction Mib1 SMN mediated site mutant forms Mib1 (Figure 1, B). contrast, overex-        N-terminal domain Mib1 segment SMN
pressing E3 ligase parkin did increase SMN ubiquitination,         encoded exon 6
ruling possibility overexpressing E3 ligase         investigated Mib1 interacts SMN. Using indiscriminately increase SMN ubiquitination (Figure S2).          monoclonal antibody SMN, endogenous Mib1
performed vitro ubiquitination assay determine            coimmunoprecipitated endogenous SMN (Figure 4A), indicat-
Mib1 directly ubiquitinates SMN. Purified recombinant Mib1             ing proteins associate. interaction detectable 
SMN proteins incubated reaction buffer containing ubiq-            tween SMN Mib2, homologue Mib1 (Koo etÂ  al., 2005b)
uitin, ubiquitin-activating enzyme (E1), ubiquitin-conjugating     similar structural domain organization (Figure 4B), demon-
enzyme (E2) UBCH5b. Mib1 ubiquitinates SMN cell-free sys-          strating specificity interaction Mib1 SMN. tem, seen Western blots probed antibody polyubiq-         characterize interaction Mib1 SMN, 

1864â€ƒ |â€ƒ D. Y. Kwon et al.	                                                                                             Molecular Biology Cell
 FIGURE 1:â€‚   NSC-34 cells transfected 2 Î¼g Mib1 1 Î¼g HA-Ub cDNAs. cells harvested 48 h
later, endogenous SMN immunoprecipitated. Immunoprecipitated proteins resolved SDSâ€“PAGE, proteins analyzed Western blotting. blots probed HA antibody detect ubiquitinated
SMN. (B) Schematic representation Mib1 protein domains. (C) Cell-free SMN ubiquitination assay. Recombinant SMN incubated E1 E2 (UBCH5B) enzymes Mib1 ubiquitin 1 h 37Â°C. Western blots probed anti-polyubiquitin antibody (FK1). (D) Pulseâ€“chase analysis endogenous SMN presence 2 Î¼g Mib1-myc Mib1-C1009S-myc. data represent mean Â± SEM independent experiments.


used purified recombinant Mib1 pull assays purified        tion mutant, exception SMNÎ”6, coimmunoprecipitated
glutathione S-transferase (GST)-SMN GST          Mib1, indicating SMN exon 6 required interac-
GST-SMN GST pulled Mib1 (Figure 4C),             tion Mib1 (Figure 4E).  deletion firming direct interaction SMN Mib1 showing           SMN exon 6 disrupts binding Mib1 markedly  factors, including members SMN complex,       duced ubiquitination Mib1 (Figure 4F). domain
required interaction.                                          encoded exon 6 mediates SMN oligomerization, examined
    asked domains Mib1 mediate interaction         SMN oligomerization required Mib1 interact with SMN. Using constructs containing various regions Mib1       SMN. Mib1 coimmunoprecipitated wild-type
gene, performed coimmunoprecipitation assays map           SMN patient-derived SMN mutants SMN-G279V
mains Mib1 required SMN binding. N-terminal         SMN-Y272C, efficiently self-associate oli-
gion Mib1 (m132-myc) coimmunoprecipitated SMN,              gomerize (Figure 4G). SMN oligomerization required structs containing middle ankyrin repeat C-terminal RING        Mib1 association.
domain showed weak interaction (Figure 4D). Additionally,             sought determine Mib1 contributes  C-terminal active-site mutation C1009S effect SMN         stability SMNÎ”7. overexpressing Mib1 resulted
binding (Figure 4D). map regions SMN mediate bind-       greater ubiquitination SMNÎ”7 length SMN, ing Mib1, cotransfected FLAG-tagged Mib1 construct            knocking Mib1 increased SMNÎ”7 stability (Figure 5, constructs expressing length SMN SMN lacking        B). data suggest instability SMNÎ”7 seven translated exons. length SMN dele-      ubiquitination Mib1.


Volume 24â€ƒ June 15, 2013	                                                                          Mib1 targets SMN degradationâ€ƒ |â€ƒ 1865â€ƒ
                                                                                                    interference (RNAi) feeding
                                                                                                   (Timmons  1998; Timmons etÂ  al.,
                                                                                                   2001). Knocking Mib-1 C. elegans
                                                                                                   orthologue increased pharyngeal
                                                                                                   pumping rates smn-1â€“deficient animals,
                                                                                                   did reach statistical significance
                                                                                                   (p = 0.06, Figure S3). RNAi feeding                                                                                                    generally effective neurons                                                                                                    tissues (Kamath etÂ al., 2001; Timmons
                                                                                                   etÂ  al., 2001; Rual etÂ  al., 2004). circum-
                                                                                                   vent difficulty, increased neuronal
                                                                                                   sensitivity RNAi feeding ectopic neu-
                                                                                                   ronal expression SID-1 double-
                                                                                                   stranded RNA channel smn-1 animals
                                                                                                   (Calixto etÂ al., 2010). sensitized 
                                                                                                   ground, mib-1 RNAi significantly amelio-
                                                                                                   rated smn-1 pharyngeal pumping 
                                                                                                   fects (Figure 6A; p = 0.04), suggesting                                                                                                    MIB-1 conserved cross-species modifier
                                                                                                   SMN loss function defects.                                                                                                    Mib1 plays important role Notch func-
                                                                                                   tion (Itoh etÂ  al., 2003; Lai etÂ  al., 2005; Le
                                                                                                   Borgne etÂ al., 2005), examined                                                                                                    MIB-1 impact perturbations
                                                                                                   Notch signaling. Loss Notch coli-
                                                                                                   gand function (Komatsu etÂ al., 2008; Singh
                                                                                                   etÂ  al., 2011) smn-1 mutants did                                                                                                    ameliorate pharyngeal pumping defect
                                                                                                   smn-1(ok355);osm-11(rt142) animals
                                                                                                   (Figure 6B). rule SMN-
                                                                                                   independent effects, data suggest
                                                                                                   MIB-1 directly impacts SMN-1 function
                                                                                                   independent Notch signaling.

                                                                                                   DISCUSSION
                                                                                                    study, provide evidence
                                                                                                    E3 ligase Mib1 ubiquitinates FIGURE 2:â€‚ Effects Mib1 overexpression SMN protein levels gem number.                     catalyzes SMN protein degradation.   HEK-293T cells transfected 1 2 Î¼g Mib1-myc cDNA. 24 h              effects associated changes transfection, cells treated vehicle (water) 1 Î¼M bortezomib harvested 6 h SMN mRNA expression ob-
later. Cell lysates resolved SDSâ€“PAGE, densitometry resulting bands          served ligase-defective point mutant
performed using ImageJ software (National Institutes Health). SMN protein levels                                                                                                     Mib1 expressed. Knocking Mib1
corrected based actin values. data represent mean Â± SEM independent
                                                                                                    increases SMN protein levels cultured
experiments. *, p < 0.05. (B) Overexpression Mib1 decreases gem number intensity cultured cells. HeLa cells transfected Mib1-myc Mib-C1009S-myc 24 h. cells cells partially rescues neuromuscular fixed stained antibodies SMN myc appropriate Alexa Fluor               defect SMN deficiency C. elegans.
secondary antibodies visualization microscopy. number intensity nuclear gems data indicate Mib1 reduces SMN quantitated using Nikon NIS Elements software. 300 cells counted        protein stability targeting degrada-
transfection condition. data represent mean Â± SEM independent experiments.            tion proteasome represents ***, p < 0.001.                                                                                     new modifier SMA phenotype.
                                                                                                        inverse correlation SMN2
Loss C. elegans orthologue mib-1 ameliorates                     copy number SMA severity indicates increasing SMN pro-
neuromuscular defects caused smn-1 loss function                      tein levels ameliorate disease phenotype. Mechanisms Potential cross-species conservation SMN-MIB1 interaction            increase SMN protein levels actively pursued thera- examined C. elegans. C. elegans genome single              peutic options SMA. Inhibiting degradation SMN orthologue SMN, smn-1. Homozygous smn-1 loss function                 way increase steady-state level. Inhibiting proteasome 
causes developmental delay, impaired locomotion, reduced pha-               creases SMN levels cultured cells SMA model mice (Kwon
ryngeal pumping, larval lethality (Briese etÂ al., 2009; Dimitriadi      etÂ al., 2011), ameliorates disease phenotype. Identifying
etÂ al., 2010). complete loss SMN function causes le-            enzymes specifically target SMN degradation thality, smn-1 animals survive days partial          provide new therapeutic targets. overexpression
maternal rescue. C. elegans orthologue human MIB1             Mib1 increases ubiquitination SMN, indicated increased
gene mib-1 (Berndt etÂ  al., 2011). assess genetic interactions,          ubiquitinâ€“SMN conjugates. overexpressed Mib1 ac- decreased Mib-1 levels smn-1â€“deficient animals RNA                 celerates rate SMN degradation, knockdown Mib1


1866â€ƒ |â€ƒ D. Y. Kwon et al.	                                                                                           Molecular Biology Cell
                                                                                                      ubiquitinates SMNÎ”7 greater extent
                                                                                                     length SMN. propose                                                                                                      increased Mib1-mediated ubiquitination                                                                                                      SMNÎ”7 account                                                                                                      relative instability SMNÎ”7 protein.
                                                                                                     Consistent  reducing Mib1 levels
                                                                                                     results increased stability SMNÎ”7
                                                                                                     protein.
                                                                                                         interaction SMN
                                                                                                     Mib1 likely mediated domain
                                                                                                     encoded exon 6. Missense mutations                                                                                                      exon 6 deletion exon 7 disrupt SMNâ€™s
                                                                                                     ability oligomerize (Lorson etÂ  al., 1998;
                                                                                                     Pellizzoni etÂ al., 1999; Zhang etÂ al., 2003; Le
                                                                                                     etÂ  al., 2005), resulting severe SMA;                                                                                                      SMN fails oligomer-
                                                                                                     ize rapidly degraded (Burnett etÂ al., 2009).
                                                                                                     mutation SMN exon 6 disrupts oli-
                                                                                                     gomerization (Y272C) destabilizes                                                                                                      SMN protein, cells patient                                                                                                      mutation similar SMN levels                                                                                                      homozygous deletion SMN1
                                                                                                     (Lefebvre etÂ al., 1997). possibility                                                                                                      Mib1 interacts SMN                                                                                                      oligomerized, exon 6 mediates SMN
                                                                                                     oligomerization.  likely
                                                                                                     Mib1 interacts SMN                                                                                                      patient-derived mutations G279V                                                                                                      Y272C, efficiently oligomerize
                                                                                                     (Figure 4G). likely                                                                                                      inability SMN oligomerize increases
                                                                                                     likelihood binding Mib1.                                                                                                      exon 6 domain mediates SMN self-asso-
                                                                                                     ciation (Lorson etÂ al., 1998), domain                                                                                                      available interaction Mib1
                                                                                                     SMN oligomerizes complex.
                                                                                                     explain increased stability                                                                                                      complexed SMN, inaccessible                                                                                                      Mib1 unlikely ubiquitinated
                                                                                                     degraded.
FIGURE 3:â€‚   HEK-293T cells transfected 100 pmol scrambled siRNA                article preparation,
Mib1 siRNA 72 h. Mib1 SMN protein levels determined 72 h Western
                                                                                                     Usp9x  known fat facets, FAM), blotting. (B) HEK-293T cells transfected 100 Î¼M negative control miRNA                                                                                                      deubiquitinating enzyme (DUB), miR-137 72 h. SMN protein levels determined Western blotting. data represent mean Â± SEM independent experiments. (C) SMA patientâ€“derived fibroblasts (3813)          stabilize SMN reducing ubiquitina- transfected Mib1 siRNA scrambled control. Cells harvested 72 h post-               tion (Han etÂ al., 2012). Interestingly, Usp9x/
transfection, Mib-1 mRNA SMN protein levels assessed RT-PCR Western              FAM interacts Mib1 (Choe etÂ  al.,
blot analysis, respectively. (D) HEK-293T cells transfected Mib1 siRNA, miR-137,        2007), points possibility scrambled control. Cells harvested 72 h posttransfection, SMN mRNA level                Usp9x Mib1 act concert regulate
analyzed RT-PCR. *, p < 0.05; **, p < 0.01; ***, p < 0.001.                                       SMN protein levels.
                                                                                                         genetic modifiers SMA siRNAs microRNA mir-137 stabilizes SMN. data           reported humans: SMN2 plastin3. genome-wide RNAi
demonstrate Mib1-mediated ubiquitination SMN enhances               screen C. elegans Drosophila deficient SMN identified degradation decreases steady-state SMN protein levels.              genes modify disease phenotype model sys-
    SMA patients homozygous deletion                 tems (Dimitriadi etÂ al., 2010). SMN deficiency C. elegans char-
SMN1 gene, retain copy SMN2. major             acterized marked reduction rate pharyngeal pumping.
SMN2 gene product truncated SMNÎ”7 protein  based             Mib1 knockdown RNAi partially rescues ability extend survival SMA mice, likely retains         SMN-deficient phenotype C. elegans, indicating Mib1 function unstable rapidly degraded. instability           modifier SMA. biochemical data suggest Mib1 pro-
SMNÎ”7 thought number factors, including            motes SMN degradation proteasome.  inability self-associate (Lorson etÂ al., 1998; Burnett etÂ al., 2009)     rule possibility SMN-independent pathways involving presence degradation signal promotes rapid            functions Mib1 responsible partial rescue turnover (Cho Dreyfuss, 2010). study, Mib1         neuromuscular phenotype. Nonetheless, identification new


Volume 24â€ƒ June 15, 2013	                                                                                Mib1 targets SMN degradationâ€ƒ |â€ƒ 1867â€ƒ
                                                                                               modifier SMA phenotype partic-
                                                                                              ular importance, given currently limited
                                                                                              number targets favorable thera-
                                                                                              peutic index.
                                                                                                  steady-state level protein                                                                                               governed balance protein
                                                                                              synthesis degradation. Strategies 
                                                                                              crease SMN protein synthesis regulat-
                                                                                              ing gene, stabilizing mRNA, al-
                                                                                              tering splicing promote inclusion exon
                                                                                              7 pursued SMA therapeutic
                                                                                              development. SMN2 gene pro-
                                                                                              duces length SMN protein sug-
                                                                                              gests strategies slow degradation
                                                                                              therapeutic options.                                                                                               SMN ubiquitinated degraded                                                                                               proteasome, retarding turnover                                                                                               blocking proteasome inhibit-
                                                                                              ing SMN ubiquitination useful                                                                                               treating SMA. shown SMA
                                                                                              mice treated proteasome inhibitor
                                                                                              bortezomib reduced pathology                                                                                               improved motor function (Kwon etÂ al., 2011).
                                                                                               toxicity available protea-
                                                                                              inhibitors preclude chronic use                                                                                               SMA patients. small molecule inhibi-
                                                                                              tors proteasome devel-
                                                                                              oped research clinical use, E3 ubiq-
                                                                                              uitin ligases emerging targets                                                                                               disease treatment, confer                                                                                               substrate specificity UPS. Drugs                                                                                               inhibit E3 ligases involved cell cycle regu-
                                                                                              lation cell proliferation currently 
                                                                                              der study treat various types cancer.
                                                                                              E3 ligase, murine double minute 2
                                                                                              (MDM2), regulates tumor suppressor
                                                                                              p53 represses role cell cycle arrest
                                                                                              apoptosis (Fakharzadeh etÂ  al., 1993;
                                                                                              Haupt etÂ al., 1997). Inhibitors human
                                                                                              homologue MDM2 shown FIGURE 4:â€‚   Endogenous SMN immunoprecipitated HEK-293T cell lysates       reduce tumor growth induce tumor cell
antibody SMN, immunoprecipitates resolved SDSâ€“PAGE. Association           apoptosis vitro, providing incentive Mib1 determined Western blot analysis using antibody Mib1. (B) Protein lysates   targeting MDM2 function treat cancer HEK-293T cells immunoprecipitated SMN antibody. Mib1                  vivo (Issaeva etÂ  al., 2004; Koblish etÂ  al.,
coimmunoprecipitated SMN, Mib2 detected Western blot analysis.                2006). High-throughput small molecule
Membranes probed anti-SMN, anti-Mib1, anti-Mib2 antibodies. (C) GST                                                                                               compound screens used iden-
GST-SMN used pull purified recombinant Mib1 protein. (D) Myc-tagged Mib1
                                                                                              tify inhibitors E3 ligases (Davydov etÂ  al.,
constructs containing length truncated transcripts Mib1 gene transiently transfected HEK-293T cells. Immunoprecipitation using anti-myc antibody   2004; Huang etÂ  al., 2005). screens performed, interaction endogenous SMN detected Western blot analysis      adapted identify molecules using anti-SMN antibody. (E) HEK-293T cells transfected 0.5 Î¼g length SMN   disrupt interaction ligase cDNA various SMN constructs single-exon deletion, 2 Î¼g Mib1-FLAG. Mib1-         protein substrate, confer
FLAG immunoprecipitated resolved SDSâ€“PAGE gel. Western blots probed         greater selectivity reduce target ef- antibodies FLAG Myc determine binding Mib1 SMN. (F) HEK-293T cells       fects. Nutlin, inhibits interaction transfected 2 Î¼g Mib1-FLAG, 1 Î¼g HA-Ub, 1 Î¼g length SMN-myc      MDM2 p53, identified SMNÎ”6-myc. cells harvested 48 h later, myc-tagged SMN immunoprecipitated         small molecule screen (Vassilev etÂ al., 2004)
using anti-myc antibody, proteins separated SDSâ€“PAGE detected                                                                                               currently evaluated early-
Western blotting. blots probed HA antibody detect ubiquitinated SMN.
                                                                                              phase clinical trials. new, toxic,
(G) HEK-293T cells transfected 2 Î¼g Mib1-myc 0.5 Î¼g GFP-tagged
wild-type SMN, SMN G279V, SMN Y272C. cells harvested 48 h later, SMN          general proteasome inhibitors  immunoprecipitated anti-myc antibody resolved SDSâ€“PAGE gel. Western      veloped, targeting E3 ligase selec-
blots probed antibodies myc GFP determine interaction Mib1         tively tags SMN degradation wild-type SMN disease-associated mutants.                                              safer effective. Small molecule



1868â€ƒ |â€ƒ D. Y. Kwon et al.	                                                                                      Molecular Biology Cell
                                                                                                  (Sigma-Aldrich, St. Louis, MO) used                                                                                                  1:1000 dilution; anti-FLAG M2 (Sigma-
                                                                                                 Aldrich), anti-Myc 9E10 (Santa Cruz Biotech-
                                                                                                 nology, Santa Cruz, CA), anti-HA (Sigma-
                                                                                                 Aldrich), anti-actin (Sigma-Aldrich)                                                                                                  used 1:5000 dilution. Anti-Mib1 serum
                                                                                                 gift Junmin Peng (St. Jude
                                                                                                 Childrenâ€™s Research Hospital). signal
                                                                                                 visualized secondary antibody
                                                                                                 (anti-mouse anti-rabbit immunoglobulin-
                                                                                                 horseradish peroxidase, 1:3000â€“
                                                                                                 10,000 dilution) using chemiluminescence
                                                                                                 detection (Perkin Elmer-Cetus,
FIGURE 5:â€‚   HEK-293T cells transfected 2 Î¼g length SMN SMNÎ”7            Waltham, MA).
1 Î¼g Mib1-FLAG HA-Ub cDNAs. cells harvested 48 h later, SMN                         immunoprecipitation experiments,
immunoprecipitated resolved SDSâ€“PAGE, proteins analyzed Western           cell lysates clarified centrifugation
blotting. blots probed HA antibody detect ubiquitinated SMN.                 precleared pan-mouse immuno-
(B) Pulseâ€“chase analysis length SMN SMNÎ”7, absence presence 2 Î¼g        globulin G (IgG) Dynabeads (Invitrogen) Mib1-myc. data represent mean Â± SEM experiments.                                1 h 4Â°C. lysates incubated
                                                                                                 1 Î¼g antibody 2 h overnight
screens identify inhibitors Mib1 lead novel thera-     incubated pan-mouse IgG Dynabeads 1 h peutics SMA.                                                         rotator 4Â°C. beads washed NP-40 buffer                                                                          times boiled SDS gel-loading buffer. Eluted proteins
MATERIALS METHODS                                                    run SDSâ€“PAGE Western blotting.
Plasmids miRNA                                                           pull assay, 5 Î¼g purified recombinant Mib1 protein
Plasmids encoding human length truncated Mib1              purchased Origene (Rockville, MD; TP321377) incubated
constructed previously described (Itoh etÂ al., 2003). Mib1 shRNA      GST SMN-GST beads 4Â°C rotator overnight. Samples nonsilencing control purchased SABiosciences               spun  beads washed times NP-40
(KM26177G) pre-miR miRNA precursors (control miR-137)            buffer. Following wash, beads boiled SDS gel- purchased Ambion (PM10513). Myc-Parkin obtained            loading buffer 5 min, eluted proteins processed Chitnis lab.                                                    Western blotting.

Cell culture, transfection, Western blotting                          RNA extraction quantification
Human embryonic kidney HEK-293T NSC34 cells main-                Cells homogenized 500 Î¼l TRIzol reagent (Invitrogen) tained 37Â°C 5  CO2 DMEM (Invitrogen, Carlsbad, CA)             spun 10 min 4Â°C. microliters chloroform supplemented 10  FBS penicillin/streptomycin/glutamine           added supernatant, mixture vortexed spun
(Invitrogen). Cells plated culture plate tran-    aqueous upper phase transferred 
siently transfected 0.5â€“4 Î¼g plasmid DNA using           tube, 250 Î¼l isopropanol 50 Î¼l 3M sodium acetate FuGENE HD transfection reagent (Roche Applied Science, India-             added. RNA pelleted, washed 70  ethanol,
napolis,  according manufacturerâ€™s protocol. total          resuspended 100 Î¼l DNase- RNase-free water. Total DNA used transfection kept constant             RNA quantified absorption 260 nm, 450 ng experiment adding appropriate vector                RNA sample converted cDNA using High Capacity
plasmid. Cells harvested 24â€“48 h posttransfection.                   cDNA Reverse Transcription kit (Applied Biosystems, Bedford, MA).
    siRNA miRNA transfections, HEK-293T cells                Aliquots 20 Î¼l quantitative PCRs run triplicate using plated subconfluently culture dish transfected          ABI Prism 7900 sequence detection (Applied Biosystems). 100 pmol siRNA/miRNA 10 Î¼l Lipofectamine 2000              levels hypoxanthine phosphoribosyltransferase (HPRT;
(Invitrogen). 48 h transfection, cells transfected    control), SMN, Mib1 transcripts quantified thresh- siRNA/miRNA 24 h harvested total 72 h        old cycle primers purchased Applied Biosystems.
transfection.
                                                                          Immunohistochemical analysis gem numbers
Western blotting, immunoprecipitation,                                    gem number assayed 24 h transfection myc-Mib1 pull assays                                                      myc-Mib1-C1009S. cells fixed, permeabilized, im-
Transfected cells lysed NP-40 lysis buffer (1  NP-40,      munostained anti-SMN anti-myc antibodies. Blinded counts
50 mM Tris-HCl, 150 mM NaCl, pH 8.0) RIPA buffer (1  Triton            gems performed 300 nuclei condition.
X-100, 1  sodium deoxycholate, 150 mM NaCl, 0.1  SDS, pH 8.0) quantified using BCA Protein Assay Kit (Pierce, Rockford,      vitro ubiquitination Western blotting. Equal amounts protein lysate (15 Î¼g)        Recombinant SMN protein (Enzo Life Sciences, Farmingdale, NY)
run separated 10  SDSâ€“PAGE (Invitrogen) transferred          incubated ubiquitin, E1 ubiquitin-activating enzyme polyvinylidene fluoride membrane (Invitrogen).             (Boston Biochem, Cambridge, MA), E2 ubiquitin-conjugating probed appropriate antibodies 5  milk washed         enzyme, UBCH5B, recombinant Mib1 (OriGene Technologies, Tris-buffered saline Tween 20. Antibodies: anti-SMN (BD          Rockville, MD) reaction buffer (50 mM Tris-HCl, pH 7.5, 2 mM ATP,
Transduction), anti-Mib1 (Epitomics, Burlingame, CA), anti-Mib2       4 mM MgCl2, 2 mM dithiothreitol [DTT]) 1 h 37Â°C. Reactions


Volume 24â€ƒ June 15, 2013	                                                                            Mib1 targets SMN degradationâ€ƒ |â€ƒ 1869â€ƒ
                                                                                                         Construction RNAi feeding clone                                                                                                         Y47D3A.22/mib-1
                                                                                                        796â€“base pair PCR product correspond-
                                                                                                        ing C. elegans mib-1 cDNA (Berndt
                                                                                                        etÂ al., 2011) cloned L4440 RNAi
                                                                                                        feeding vector; followed                                                                                                         transformation HT115(DE3) bacte-
                                                                                                        rial strain (Timmons  1998;
                                                                                                        Timmons etÂ al., 2001). Primers amplifica-
                                                                                                        tion ACH72 5â€™-tgatgctagcgcagcttctc-
                                                                                                        ctgttgcgtg-3â€™ ACH73 5â€™-tgatctcgaÂ­ggcgÂ­
                                                                                                        ggagccgaÂ­tttgaactg-3â€™.

                                                                                                        C. elegans pharyngeal pumping assay
                                                                                                      pharyngeal pumping assay 
                                                                                                      formed previously described (Dimitriadi
                                                                                                      etÂ al., 2010). Briefly, eggs hatched L4440
                                                                                                      control       vector     (L4440     [RNAi])                                                                                                            (Y47D3A.22/mib-1[RNAi]) bacterial feeding
                                                                                                      strains (Kamath Ahringer, 2003) FIGURE 6:â€‚ Knockdown C. elegans orthologue Mib1 ameliorates pharyngeal
pumping neuromuscular defects smn-1 loss function animals.   mib-1 knockdown                  reared 2 d 25Â°C 1 d 20Â°C.
significantly increases pharyngeal pumping smn-1 deficient animals SID-1 sensitization,       Pumping rates determined using increases RNAi neuronal sensitivity. (B) Loss Notch coligand function smn-1           AxioCam ICc1 camera Zeiss Stemi SV11
mutants did ameliorate pharyngeal pumping defect smn-1(ok355);osm-11(rt142)                microscope (Carl Zeiss, Jena, Germany). animals. Pharyngeal pumping events measured control mib-1 RNAi-fed                   pumping event scored pharyngeal
animals. error bars SEM; *, p < 0.05.                                                         grinder movement axis, average
                                                                                                      pumping rates (Â± SEM) derived quenched 30 Î¼l 5Ã— Laemmli sample buffer (200 mM Tris,          blinded manner independent trials (n â‰¥ 30 ani-
pH 6.8, 32  [vol/vol] glycerol, 6.4  [wt/vol] SDS, 0.32  [wt/vol] bro-      mals total). Heterozygous homozygous smn-1 loss function
mophenol blue, 200 mM DTT), boiled 5 min, separated             animals distinguished green fluorescent protein (GFP) fluo- SDSâ€“PAGE. SMN ubiquitination analyzed Western blot-              rescence. wild-type (N2) smn-1 loss function heterozy-
ting, using antibody polyubiquitin (FK1; Enzo Life Sciences).       gous animals showed pumping rates significantly dif-
                                                                            ferent.  heterozygous smn-1 loss function animals Pulseâ€“chase protein labeling                                                used controls study.
Pulseâ€“chase analysis performed previously described (Burnett
etÂ  al., 2009). brief, HEK-293T cells incubated cysteine-        Statistics
methionineâ€“free medium (Sigma-Aldrich) 2 h 12 h;            biochemical data analyzed GraphPad Prism
followed incubation cysteine-methionineâ€“free medium contain-          software package (GraphPad Software, San Diego, CA) com-
ing 100 Î¼Ci [35S]-labeled cysteine-methionine (GE Healthcare,            pared statistically t test way analysis variance,
Piscataway, NJ) 1 h. labeling, cells washed         Newman-Keuls multiple-comparison post hoc correction. culture medium containing 10-fold excess unlabeled methi-         compare differences groups, performed onine cysteine (5 mM  incubated            nonparametric equality medians test, data medium. cells collected indicated time points          normally distributed. statistically significant, processed immunoprecipitation anti-SMN antibody (BD            pairwise comparison treatment groups Transduction Laboratories). Immunoprecipitations carried           using Mann-Whitney test. 6 h 4Â°C antibodies bound protein G-Sepharose (Sigma-
Aldrich). washes lysis buffer (100 mM NaCl, 10 mM          ACKNOWLEDGMENTS
Tris-HCl, pH 7.4, 2.5 mM MgCl2, 0.1  NP-40, protease [Roche])           thank Liu Yang (University Arkansas) myc-tagged phosphatase inhibitor cocktails (Sigma-Aldrich), bound proteins         FL-SMN deletion mutant cDNAs. work supported eluted boiling SDSâ€“PAGE sample buffer. Immunocom-                intramural research funds National Institute Neurological
plexes separated 10  SDSâ€“PAGE. gels dried              Disorders Stroke National Institutes Healthâ€“National
exposed phosphorimager screen, signal visualized           Institute Neurological Disorders Stroke (NS066888) C.H. Storm phosphorimager (Molecular Dynamics, Piscat-
away, NJ). Densitometric analysis protein bands carried      REFERENCES
                                                                            Barsi JC, Rajendra R, Wu JI, Artzt K (2005). Mind bomb1 ubiquitin ligase
using ImageQuant PhosphorImager software (Molecular Dynamics).
                                                                                  essential mouse embryonic development Notch signaling. Mech
                                                                                  Dev 122, 1106â€“1117.
C. elegans strains                                                            Berndt JD, Aoyagi  Yang P, Anastas JN, Tang L, Moon RT (2011). Mind-
TU3311 uIs60 [unc-119p::yfp, unc-119p::sid-1] (Calixto etÂ al., 2010),             bomb 1, E3 ubiquitin ligase, forms complex RYK activate
HA2258 smn-1(ok355)/hT2[bli-4(e937) let-?(q782) qIs48]  III); uIs60             Wnt/Î²-catenin signaling. J Cell Biol 194, 737â€“750.
                                                                              Brenner S (1974). genetics Caenorhabditis elegans. Genetics 77,
(Briese etÂ al., 2009), HA2201 smn-1(ok355)/hT2[bli-4(e937) let-               71â€“94.
?(q782) qIs48]  III); osm-11(rt142)X maintained 20Â°C ac-            Briese M, Esmaeili B, Fraboulet S, Burt EC, Christodoulou S, Towers PR,
cording standard protocols (Brenner, 1974).                                    Davies KE, Sattelle DB (2009). Deletion smn-1, Caenorhabditis


1870â€ƒ |â€ƒ D. Y. Kwon et al.	                                                                                                 Molecular Biology Cell
     elegans ortholog spinal muscular atrophy gene, results locomo-      Kwon DY, Motley WW, Fischbeck KH, Burnett BG (2011). Increasing expres-
    tor dysfunction reduced lifespan. Hum Mol Genet 18, 97â€“104.                   sion decreasing degradation SMN ameliorate spinal muscular
Burnett BG, Munoz E, Tandon  Kwon DY, Sumner CJ, Fischbeck KH                       atrophy phenotype mice. Hum Mol Genet 20, 3667â€“3677.
    (2009). Regulation SMN protein stability. Mol Cell Biol 29, 1107â€“1115.     Lai EC, Roegiers F, Qin X, Jan YN, Rubin GM (2005). ubiquitin ligase
Calixto  Chelur D, Topalidou  Chen X, Chalfie M (2010). Enhanced neu-             Drosophila Mind bomb promotes Notch signaling regulating     ronal RNAi C. elegans using SID-1. Nat Methods 7, 554â€“559.                     localization activity Serrate Delta. Development 132,
Chang HC etÂ al. (2008). Modeling spinal muscular atrophy Drosophila.               2319â€“2332.
    PLoS 3, e3209.                                                            Le TT, Pham LT, Butchbach  Zhang HL, Monani UR, Coovert DD,
Chang HC, Hung WC, Chuang YJ, Jong YJ (2004). Degradation survival                 Gavrilina  Xing L, Bassell GJ, Burghes AH (2005). SMNDelta7,     motor neuron (SMN) protein mediated ubiquitin/proteasome               major product centromeric survival motor neuron (SMN2) gene,
    pathway. Neurochem Int 45, 1107â€“1112.                                             extends survival mice spinal muscular atrophy associates
Chen W, Casey Corliss D (2004). modules zebrafish Mind bomb                  length SMN. Hum Mol Genet 14, 845â€“857.
    work cooperatively promote Delta ubiquitination endocytosis.           Le Borgne R, Remaud S, Hamel S, Schweisguth F (2005). distinct E3
    Dev Biol 267, 361â€“373.                                                            ubiquitin ligases complementary functions regulation Cho S, Dreyfuss G (2010). degron created SMN2 exon 7 skipping               delta serrate signaling Drosophila. PLoS Biol 3, e96.
    principal contributor spinal muscular atrophy severity. Genes Dev 24,      Lefebvre S etÂ al. (1995). Identification characterization spinal
    438â€“442.                                                                          muscular atrophy-determining gene. Cell 80, 155â€“165.
Choe EA, Liao L, Zhou JY, Cheng D, Duong DM, Jin P, Tsai LH, Peng J               Lefebvre S, Burlet P, Liu Q, Bertrandy S, Clermont O, Munnich  Dreyfuss
    (2007). Neuronal morphogenesis regulated interplay              G, Melki J (1997). Correlation severity SMN protein level     cyclin-dependent kinase 5 ubiquitin ligase mind bomb 1.                   spinal muscular atrophy. Nat Genet 16, 265â€“269.
    J Neurosci 27, 9503â€“9512.                                                     Lorson CL, Androphy EJ (2000). exonic enhancer required inclusion
Coovert DD, Le TT, McAndrew PE, Strasswimmer J, Crawford  Mendell                  essential exon SMA-determining gene SMN. Hum Mol
    JR, Coulson SE, Androphy EJ, Prior TW, Burghes AH (1997). survival            Genet 9, 259â€“265.
    motor neuron protein spinal muscular atrophy. Hum Mol Genet 6,             Lorson CL, Hahnen E, Androphy EJ, Wirth B (1999). single nucleotide     1205â€“1214.                                                                        SMN gene regulates splicing responsible spinal muscular
Davydov IV, Woods D, Safiran YJ, Oberoi P, Fearnhead HO, Fang S, Jensen               atrophy. Proc Natl Acad Sci USA 96, 6307â€“6311.
    JP, Weissman  Kenten JH, Vousden KH (2004). Assay ubiquitin            Lorson CL, Strasswimmer J, Yao JM, Baleja JD, Hahnen E, Wirth B, Le T,
    ligase activity: high-throughput screen inhibitors HDM2. J Biomol          Burghes AH, Androphy EJ (1998). SMN oligomerization defect corre-
    Screen 9, 695â€“703.                                                                lates spinal muscular atrophy severity. Nat Genet 19, 63â€“66.
Dimitriadi M etÂ al. (2010). Conserved genes act modifiers invertebrate      McAndrew PE, Parsons DW, Simard LR, Rochette C, Ray PN, Mendell JR,
    SMN loss function defects. PLoS Genet 6, e1001172.                             Prior TW, Burghes AH (1997). Identification proximal spinal muscular
Fakharzadeh SS, Rosenblum-Vos L, Murphy M, Hoffman EK, George DL                      atrophy carriers patients analysis SMNT SMNC gene copy
    (1993). Structure organization amplified DNA double minutes             number. J Hum Genet 60, 1411â€“1422.
    containing mdm2 oncogene. Genomics 15, 283â€“290.                           McWhorter ML, Monani UR, Burghes AH, Beattie CE (2003). Knockdown Han KJ, Foster DG, Zhang NY, Kanisha K, Dzieciatkowska M, Sclafani RA,                survival motor neuron (Smn) protein zebrafish causes defects     Hansen KC, Peng J, Liu CW (2012). Ubiquitin-specific protease 9x deu-             motor axon outgrowth pathfinding. J Cell Biol 162, 919â€“931.
    biquitinates stabilizes spinal muscular atrophy proteinâ€”survival      Monani UR, Lorson CL, Parsons DW, Prior TW, Androphy EJ, Burghes AH,
    motor neuron. J Biol Chem 287, 43741â€“43752.                                       McPherson JD (1999). single nucleotide difference alters splicing
Haupt Y, Maya R, Kazaz  Oren M (1997). Mdm2 promotes rapid deg-                 patterns distinguishes SMA gene SMN1 copy gene SMN2.
    radation p53. Nature 387, 296â€“299.                                             Hum Mol Genet 8, 1177â€“1183.
Hsieh-Li HM, Chang JG, Jong YJ, Wu MH, Wang NM, Tsai CH, Li H (2000).             Pellizzoni L, Charroux B, Dreyfuss G (1999). SMN mutants spinal muscular
    mouse model spinal muscular atrophy. Nat Genet 24, 66â€“70.                   atrophy patients defective binding snRNP proteins. Proc Natl
Huang J, Sheung J, Dong G, Coquilla C, Daniel-Issakani S, Payan DG                    Acad Sci USA 96, 11167â€“11172.
    (2005). High-throughput screening inhibitors e3 ubiquitin          Petroski MD (2008). ubiquitin  disease, drug discovery.
    ligase APC. Methods Enzymol 399, 740â€“754.                                         BMC Biochem 9, S7.
Issaeva N, Bozko P, Enge M, Protopopova M, Verhoef LG, Masucci M,                 Prior TW, Swoboda KJ, Scott HD, Hejmanowski AQ (2004). Homozygous
    Pramanik  Selivanova G (2004). Small molecule RITA binds p53,                SMN1 deletions unaffected family members modification     blocks p53-HDM-2 interaction activates p53 function tumors.                phenotype SMN2. J Med Genet 130, 307â€“310.
    Nat Med 10, 1321â€“1328.                                                        Rual JF etÂ al. (2004). improving Caenorhabditis elegans phenome
Itoh M etÂ al. (2003). Mind bomb ubiquitin ligase essential           mapping ORFeome-based RNAi library. Genome Res 14,
    efficient activation Notch signaling Delta. Dev Cell 4, 67â€“82.              2162â€“2168.
Jarecki J, Chen X, Bernardino  Coovert DD, Whitney M, Burghes                 Singh K etÂ al. (2011). C. elegans Notch signaling regulates adult chemosen-
    Stack J, Pollok BA (2005). Diverse small-molecule modulators SMN               sory response larval molting quiescence. Curr Biol 21, 825â€“834.
    expression high-throughput compound screening: early leads           Smrt RD etÂ al. (2010). MicroRNA miR-137 regulates neuronal maturation     therapeutic spinal muscular atrophy. Hum Mol Genet 14,              targeting ubiquitin ligase mind bomb-1. Stem Cells 28, 1060â€“1070.
    2003â€“2018.                                                                    Timmons L, Court DL, (2001). Ingestion bacterially expressed
Jin Y, Blue EK, Dixon S, Shao  Gallagher PJ (2002). death-associated              dsRNAs produce specific potent genetic interference     protein kinase (DAPK)-interacting protein, DIP-1, E3 ubiquitin ligase       Caenorhabditis elegans. Gene 263, 103â€“112.
    promotes tumor necrosis factor-induced apoptosis regulates           Timmons L, (1998). Specific interference ingested dsRNA. Nature
    cellular levels DAPK. J Biol Chem 277, 46980â€“46986.                        395, 854.
Kamath RS, Ahringer J (2003). Genome-wide RNAi screening Caenorhab-            Vassilev LT etÂ al. (2004). vivo activation p53 pathway small-
    ditis elegans. Methods 30, 313â€“321.                                               molecule antagonists MDM2. Science 303, 844â€“848.
Kamath RS, Martinez-Campos M, Zipperlen P, Fraser AG, Ahringer J (2001).          Wolstencroft EC, Mattis V, Bajer AA, Young PJ, Lorson CL (2005). non-
    Effectiveness specific RNA-mediated interference ingested              sequence-specific requirement SMN protein activity: role     double-stranded RNA Caenorhabditis elegans. Genome Biol 2,                     aminoglycosides inducing elevated SMN protein levels. Hum Mol
    RESEARCH0002.                                                                     Genet 14, 1199â€“1210.
Koblish HK etÂ al. (2006). Benzodiazepinedione inhibitors Hdm2:p53          Yoo KW, Kim EH, Jung SH, Rhee M, Koo BK, Yoon KJ, Kong YY, Kim CH
    complex suppress human tumor cell proliferation vitro sensitize            (2006). Snx5, Mind bomb-binding protein, expressed 
    tumors doxorubicin vivo. Mol Cancer Ther 5, 160â€“169.                        matopoietic endothelial precursor cells zebrafish. FEBS Lett 580,
Komatsu H etÂ al. (2008). OSM-11 facilitates LIN-12 Notch signaling             4409â€“4416.
    Caenorhabditis elegans vulval development. PLoS Biol 6, e196.                 Zhang C, Li Q, Jiang YJ (2007). Zebrafish Mib Mib2 mutual E3
Koo BK etÂ al. (2005a). Mind bomb 1 essential generating functional             ubiquitin ligases common specific delta substrates. J Mol Biol
    